Larmark Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 4.00 M
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.29 Cr
- Revenue Growth -16.62%
- Profit Growth -82.29%
- Ebitda 87.45%
- Net Worth 2.09%
- Total Assets 31.94%
About Larmark Pharmaceutical
Larmark Pharmaceutical Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 May 2010 and has a history of 14 years and eight months. Its registered office is in 24 Parganas, West Bengal, India.
The Corporate was formerly known as La- Marck Pharmaceutical Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹1.29 Cr.
Samarendra Basu, Moinak Basu, Biswa Pal, and Three other members serve as directors at the Company.
Company Details
-
Location
24 Parganas, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74900WB2010PTC149728
-
Company No.
149728
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 May 2010
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
What products or services does Larmark Pharmaceutical Private Limited offer?
Larmark Pharmaceutical Private Limited offers a wide range of products and services, including Antipyretic Medication, Paracetamol Tablets, Combiflam Tablet, Antihistamines, Anti Cold Tablet, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Larmark Pharmaceutical?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Moinak Basu
|
Director | 12-Apr-2016 | Current |
|
Samarendra Basu
|
Additional Director | Current | |
|
Biswa Pal
|
Director | 20-Jan-2018 | Current |
|
Parna Basu
|
Additional Director | 22-Jan-2024 | Current |
|
Maitree Basu
|
Additional Director | 22-Jan-2024 | Current |
|
Chaitali Basu
|
Director | 03-Aug-2022 | Current |
Financial Performance of Larmark Pharmaceutical.
Larmark Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.62% decrease. The company also saw a substantial fall in profitability, with a 82.29% decrease in profit. The company's net worth moved up by a moderate rise of 2.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Larmark Pharmaceutical?
In 2023, Larmark Pharmaceutical had a promoter holding of 80.69% and a public holding of 19.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹12.90 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.60 Cr
- Axis Bank Limited : 0.44 Cr
- Bank Of India : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Feb 2024 | Axis Bank Limited | ₹0.80 M | Open |
| 20 Sep 2023 | Axis Bank Limited | ₹3.60 M | Open |
| 20 Aug 2022 | Hdfc Bank Limited | ₹6.00 M | Open |
| 26 Sep 2011 | Bank Of India | ₹2.50 M | Open |
How Many Employees Work at Larmark Pharmaceutical?
Larmark Pharmaceutical has a workforce of 30 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Larmark Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Larmark Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
